AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35881009 — intervention group
Group type: EXPERIMENTAL
Intervention: Fesoterodine (Toviaz)
Number of subjects: 6
Study 35881028 — intervention group
Group type: EXPERIMENTAL
Intervention: 18 mg lenvatinib + everolimus (5 mg daily)
Number of subjects: 343
Study 35881028 — intervention group
Group type: COMPARATOR
Intervention: 14 mg lenvatinib + everolimus (5 mg daily)
Number of subjects: 343
Study 35881109 — intervention group
Group type: EXPERIMENTAL
Intervention: Semistructured patient-centered deprescribing interview
Number of subjects: 177
Study 35881437 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic discharge order set (DOS) plus nurse follow-up calls
Number of subjects: 158
Study 35881437 — intervention group
Group type: COMPARATOR
Intervention: Enhanced standard care (ESC)
Number of subjects: 158
Study 35881467 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 13133
Study 35881826 — intervention group
Group type: EXPERIMENTAL
Intervention: TABCT product
Number of subjects: 29
Study 35881859 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention, details not available
Number of subjects: 0
Study 35881859 — intervention group
Group type: COMPARATOR
Intervention: Control group, details not available
Number of subjects: 0
Study 35881895 — intervention group
Group type: EXPERIMENTAL
Intervention: SP16 (0.2 mg/kg)
Number of subjects: 10
Study 35881895 — intervention group
Group type: COMPARATOR
Intervention: Historical placebo-treated group
Number of subjects: 10
Study 35881967 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium longum subsp. infantis
Number of subjects: 0
Study 35881967 — intervention group
Group type: COMPARATOR
Intervention: Lactobacillus reuteri
Number of subjects: 0
Study 35882366 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth prenatal care
Number of subjects: 107
Study 35882366 — intervention group
Group type: COMPARATOR
Intervention: In-person prenatal care
Number of subjects: 107
Study 35882382 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with apparent treatment-resistant hypertension (aTRH)
Number of subjects: 140
Study 35882382 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with aTRH
Number of subjects: 140
Study 35882382 — intervention group
Group type: COMPARATOR
Intervention: Patients without aTRH
Number of subjects: 140
Study 35882447 — intervention group
Group type: EXPERIMENTAL
Intervention: CRISPR/Cas9-mediated knockout of TGF-β receptor 2 in OvCa TIL
Number of subjects: 4
Study 35882452 — intervention group
Group type: EXPERIMENTAL
Intervention: Gestational diabetes mellitus (GDM)
Number of subjects: 200
Study 35882452 — intervention group
Group type: COMPARATOR
Intervention: No gestational diabetes mellitus (Control)
Number of subjects: 200
Study 35882457 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher Charlson comorbidity index (CCI score ≥6)
Number of subjects: 298
Study 35882457 — intervention group
Group type: EXPERIMENTAL
Intervention: Each additional CCI comorbidity
Number of subjects: 298
Study 35882457 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 298
Study 35882457 — intervention group
Group type: COMPARATOR
Intervention: Few comorbidities (CCI score 3-5)
Number of subjects: 298
Study 35882459 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in PMH care practices during the COVID-19 Pandemic as reported by experts through an online survey.
Number of subjects: 0
Study 35882475 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-dose EPOCH +/- rituximab
Number of subjects: 69
Study 35882514 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneal radius of curvature (CR) >7.9 mm
Number of subjects: 1127
Study 35882514 — intervention group
Group type: EXPERIMENTAL
Intervention: Fundus tessellation grades
Number of subjects: 1127
Study 35882728 — intervention group
Group type: EXPERIMENTAL
Intervention: PARPi-FL mouthwash formulation (1,000 nM of PARPi-FL dissolved in 4.5 ml of PEG 300 and 9.5 ml of water)
Number of subjects: 0
Study 35882728 — intervention group
Group type: EXPERIMENTAL
Intervention: New one-step formulation of PARPi-FL (direct addition of water into a vial containing PARPi-FL and PEG 3350)
Number of subjects: 0
Study 35882759 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant Chemoradiotherapy prior to Lateral Lymph Node Dissection
Number of subjects: 0
Study 35882759 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 35883039 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam
Number of subjects: 38
Study 35883039 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 38
Study 35883039 — intervention group
Group type: EXPERIMENTAL
Intervention: Remimazolam and Remifentanil
Number of subjects: 38
Study 35883131 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative follow-up and assessment of complications/sequalae
Number of subjects: 122
Study 35883131 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox proportional hazards model analysis
Number of subjects: 122
Study 35883131 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative complications/sequalae
Number of subjects: 122
Study 35883167 — intervention group
Group type: EXPERIMENTAL
Intervention: FBT-V
Number of subjects: 23
Study 35883226 — intervention group
Group type: EXPERIMENTAL
Intervention: Food liking ratings
Number of subjects: 51
Study 35883226 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger portion sizes (100%, 133%, 167%, 200% of baseline amounts)
Number of subjects: 51
Study 35883226 — intervention group
Group type: EXPERIMENTAL
Intervention: Selected portion of a food on the survey
Number of subjects: 51
Study 35883236 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid-free regimens
Number of subjects: 1451
Study 35883236 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid-containing regimens
Number of subjects: 1451
Study 35883458 — intervention group
Group type: EXPERIMENTAL
Intervention: Th17 gene expression analysis (IL23R, IL17, SGK1, TGFβ, RORγ, FOXO1, RANBP1)
Number of subjects: 0
Study 35883458 — intervention group
Group type: EXPERIMENTAL
Intervention: Th17 markers as diagnostic markers
Number of subjects: 0
Study 35883458 — intervention group
Group type: EXPERIMENTAL
Intervention: Th17 markers as risk factors
Number of subjects: 0
Study 35883493 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS challenged individuals
Number of subjects: 128
Study 35883493 — intervention group
Group type: COMPARATOR
Intervention: Healthy individuals
Number of subjects: 128
Study 35884990 — intervention group
Group type: EXPERIMENTAL
Intervention: whole-plant cannabis extract (CBD:THC 20:1)
Number of subjects: 150
Study 35884990 — intervention group
Group type: EXPERIMENTAL
Intervention: purified CBD and THC extract (CBD:THC 20:1)
Number of subjects: 150
Study 35884990 — intervention group
Group type: COMPARATOR
Intervention: oral placebo
Number of subjects: 150
Study 35886510 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term physical exercise (8 months of training)
Number of subjects: 98
Study 35887529 — intervention group
Group type: EXPERIMENTAL
Intervention: Panel of biomarkers (Neutrophil gelatinase-associated lipocalin, Kidney injury molecule-1, N-acetyl-beta-D-glucosaminidase, transferrin, ganglioside-activating protein GM2)
Number of subjects: 0
Study 35887529 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation
Number of subjects: 0
Study 35887529 — intervention group
Group type: COMPARATOR
Intervention: Comparison of kidney function between smokers and non-smokers
Number of subjects: 0
Study 35887809 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Exercise Program throughout Pregnancy
Number of subjects: 192
Study 35887809 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 192
Study 35887871 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozonated water irrigator used daily in conjunction with proper home oral hygiene.
Number of subjects: 0
Study 35887871 — intervention group
Group type: COMPARATOR
Intervention: Control group performing only home oral hygiene.
Number of subjects: 0
Study 35887994 — intervention group
Group type: EXPERIMENTAL
Intervention: SOFA score
Number of subjects: 57
Study 35887994 — intervention group
Group type: EXPERIMENTAL
Intervention: SIRS score
Number of subjects: 57
Study 35891387 — intervention group
Group type: EXPERIMENTAL
Intervention: dsRNA miR-29b-1*
Number of subjects: 0
Study 35891387 — intervention group
Group type: COMPARATOR
Intervention: Randomized miR-29b-1* mimics
Number of subjects: 0
Study 35891387 — intervention group
Group type: EXPERIMENTAL
Intervention: Scrambled short dsRNA sequences
Number of subjects: 0
Study 35891471 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 infection or vaccination
Number of subjects: 0
Study 35891471 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclusion of antibody avidity in serological assays
Number of subjects: 0
Study 35891515 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 seroprevalence testing
Number of subjects: 0
Study 35891697 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV infection (specifically HRV-A, HRV-B, HRV-C)
Number of subjects: 5662
Study 35891697 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV-C
Number of subjects: 5662
Study 35891697 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV-A
Number of subjects: 5662
Study 35891697 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV-B
Number of subjects: 5662
Study 35891921 — intervention group
Group type: EXPERIMENTAL
Intervention: Colorectal Bundle (CB) implemented after a 6-month control period
Number of subjects: 0
Study 35891921 — intervention group
Group type: COMPARATOR
Intervention: Local standard treatment during the 6-month control period
Number of subjects: 0
Study 35892294 — intervention group
Group type: EXPERIMENTAL
Intervention: Odronextamab
Number of subjects: 2
Study 35892341 — intervention group
Group type: EXPERIMENTAL
Intervention: Dostarlimab (JEMPERLI)
Number of subjects: 0
Study 35893347 — intervention group
Group type: EXPERIMENTAL
Intervention: Scrambler Therapy (ST)
Number of subjects: 43
Study 35893347 — intervention group
Group type: COMPARATOR
Intervention: Sham Scrambler Therapy
Number of subjects: 43
Study 35893678 — intervention group
Group type: EXPERIMENTAL
Intervention: Torque Teno Virus (TTV) detection
Number of subjects: 816
Study 35893678 — intervention group
Group type: EXPERIMENTAL
Intervention: Genomic analysis of TTV
Number of subjects: 816
Study 35893678 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-infection analysis
Number of subjects: 816
Study 35893678 — intervention group
Group type: EXPERIMENTAL
Intervention: Age correlation analysis
Number of subjects: 816
Study 35894075 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully automated online behavioral weight-loss intervention
Number of subjects: 721
Study 35894077 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibitor of aldose reductase (zopolrestat)
Number of subjects: 0
Study 35894077 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic deletion of Akr1b3
Number of subjects: 0
Study 35894077 — intervention group
Group type: COMPARATOR
Intervention: High-fat diet (control)
Number of subjects: 0
Study 35894609 — intervention group
Group type: EXPERIMENTAL
Intervention: RAASIs only
Number of subjects: 7975
Study 35894609 — intervention group
Group type: COMPARATOR
Intervention: Combination of RAASIs and other AHAs
Number of subjects: 7975
Study 35894609 — intervention group
Group type: COMPARATOR
Intervention: ACEIs only
Number of subjects: 7975
Study 35894680 — intervention group
Group type: COMPARATOR
Intervention: Traditional screening
Number of subjects: 21290
Study 35894680 — intervention group
Group type: COMPARATOR
Intervention: Criteria-based screening
Number of subjects: 21290
Study 35894680 — intervention group
Group type: COMPARATOR
Intervention: Specific referral letter
Number of subjects: 21290
Study 35894680 — intervention group
Group type: COMPARATOR
Intervention: Screening supplemented with motivation
Number of subjects: 21290
Study 35894680 — intervention group
Group type: COMPARATOR
Intervention: Referral to a specific dental treatment facility
Number of subjects: 21290
Study 35894680 — intervention group
Group type: COMPARATOR
Intervention: Post-screening referral letter based on common-sense model
Number of subjects: 21290
Study 35894729 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Ibuprofen 10 mg/kg
Number of subjects: 44
Study 35894729 — intervention group
Group type: COMPARATOR
Intervention: Oral Paracetamol 10 mg/kg
Number of subjects: 44
Study 35894761 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental implant treatment (four implants inserted bilaterally in the maxilla)
Number of subjects: 1
Study 35894761 — intervention group
Group type: EXPERIMENTAL
Intervention: Peri-implantitis operation
Number of subjects: 1
Study 35894761 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental implant treatment in patients on high-dose antiresorptive medication (HDAR)
Number of subjects: 1
Study 35895056 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (20 mg/d for 12 weeks)
Number of subjects: 40
Study 35895880 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 period
Number of subjects: 1338
Study 35895880 — intervention group
Group type: COMPARATOR
Intervention: Meningococcal conjugate ACWY vaccination
Number of subjects: 1338
Study 35896204 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 35896216 — intervention group
Group type: EXPERIMENTAL
Intervention: Benralizumab 30 mg every 8 weeks during maintenance phase
Number of subjects: 598
Study 35897011 — intervention group
Group type: EXPERIMENTAL
Intervention: Adropin, adiponectin, total testosterone, and lipid profile parameters measured in obese men
Number of subjects: 43
Study 35897011 — intervention group
Group type: COMPARATOR
Intervention: Adropin, adiponectin, total testosterone, and lipid profile parameters measured in normal-weight men
Number of subjects: 43
Study 35897011 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation analysis of adropin, adiponectin, and total testosterone
Number of subjects: 43
Study 35897011 — intervention group
Group type: EXPERIMENTAL
Intervention: Adropin as a predictor risk factor for testosterone
Number of subjects: 43
Study 35897070 — intervention group
Group type: EXPERIMENTAL
Intervention: Probabilistic unsupervised clustering model
Number of subjects: 1728
Study 35897070 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster labels added to the IMPACT extended model
Number of subjects: 1728
Study 35897070 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster with 'moderate' TBI and deranged metabolic profile
Number of subjects: 1728
Study 35897078 — intervention group
Group type: EXPERIMENTAL
Intervention: Visually tau-positive scans
Number of subjects: 0
Study 35897111 — intervention group
Group type: EXPERIMENTAL
Intervention: I-COPE intervention including patient-reported data, clinical decision support tools, and shared decision-making tools.
Number of subjects: 35
Study 35897111 — intervention group
Group type: EXPERIMENTAL
Intervention: Project ECHO® training for primary care providers.
Number of subjects: 35
Study 35897478 — intervention group
Group type: EXPERIMENTAL
Intervention: First lockdown
Number of subjects: 8121
Study 35897478 — intervention group
Group type: EXPERIMENTAL
Intervention: Second lockdown
Number of subjects: 8121
Study 35897478 — intervention group
Group type: EXPERIMENTAL
Intervention: After second lockdown
Number of subjects: 8121
Study 35897478 — intervention group
Group type: COMPARATOR
Intervention: Pre-pandemic period
Number of subjects: 8121
Study 35898141 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein-calorie supplement
Number of subjects: 0
Study 35898141 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 35898313 — intervention group
Group type: EXPERIMENTAL
Intervention: Home gardens intervention
Number of subjects: 310
Study 35898343 — intervention group
Group type: COMPARATOR
Intervention: Prototype (mRNA-1273)
Number of subjects: 597
Study 35898343 — intervention group
Group type: EXPERIMENTAL
Intervention: Omicron BA.1+Beta (1 or 2 doses)
Number of subjects: 597
Study 35898343 — intervention group
Group type: EXPERIMENTAL
Intervention: Omicron BA.1+Delta
Number of subjects: 597
Study 35898343 — intervention group
Group type: EXPERIMENTAL
Intervention: Omicron BA.1 monovalent
Number of subjects: 597
Study 35898343 — intervention group
Group type: EXPERIMENTAL
Intervention: Omicron BA.1+Prototype
Number of subjects: 597
Study 35898343 — intervention group
Group type: EXPERIMENTAL
Intervention: Omicron BA.1
Number of subjects: 597
Study 35898343 — intervention group
Group type: EXPERIMENTAL
Intervention: Omicron BA.4/BA.5
Number of subjects: 597
Study 35898518 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost BAK-free
Number of subjects: 161
Study 35898518 — intervention group
Group type: COMPARATOR
Intervention: Reference (Latanoprost with BAK)
Number of subjects: 161
Study 35898703 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous DC-based vaccine (DCVAC)
Number of subjects: 1000
Study 35899095 — intervention group
Group type: EXPERIMENTAL
Intervention: Burosumab
Number of subjects: 1
Study 35899212 — intervention group
Group type: EXPERIMENTAL
Intervention: AIDA International Registry for VEXAS syndrome
Number of subjects: 0
Study 35899271 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with Donepezil
Number of subjects: 44
Study 35899271 — intervention group
Group type: COMPARATOR
Intervention: Donepezil alone
Number of subjects: 44
Study 35899469 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 0
Study 35899784 — intervention group
Group type: EXPERIMENTAL
Intervention: COACH (Community Outreach teleheAlth program)
Number of subjects: 75
Study 35900079 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Seizure Therapy
Number of subjects: 0
Study 35900614 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body MRI (WB-MRI) using standardised MY-RADS protocol
Number of subjects: 0
Study 35900614 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised WB-MRI protocols
Number of subjects: 0
Study 35900694 — intervention group
Group type: EXPERIMENTAL
Intervention: Zanubrutinib monotherapy
Number of subjects: 211
Study 35900699 — intervention group
Group type: EXPERIMENTAL
Intervention: Polatuzumab Vedotin + Bendamustine + Rituximab (Pola+BR)
Number of subjects: 0
Study 35900699 — intervention group
Group type: COMPARATOR
Intervention: Bendamustine + Rituximab (BR)
Number of subjects: 0
Study 35900808 — intervention group
Group type: EXPERIMENTAL
Intervention: PuzzleWalk
Number of subjects: 24
Study 35900808 — intervention group
Group type: COMPARATOR
Intervention: Google Fit
Number of subjects: 24
Study 35900824 — intervention group
Group type: EXPERIMENTAL
Intervention: Posts generated by interventionists
Number of subjects: 80
Study 35900824 — intervention group
Group type: EXPERIMENTAL
Intervention: Posts that directly mentioned weight
Number of subjects: 80
Study 35900824 — intervention group
Group type: EXPERIMENTAL
Intervention: Posts that directly mentioned goals
Number of subjects: 80
Study 35900824 — intervention group
Group type: EXPERIMENTAL
Intervention: Replies from other participants
Number of subjects: 80
Study 35900824 — intervention group
Group type: EXPERIMENTAL
Intervention: Replies from interventionists
Number of subjects: 80
Study 35900824 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentiment of the conversation
Number of subjects: 80
Study 35900824 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous engagement in posts
Number of subjects: 80
Study 35900824 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning classification
Number of subjects: 80
Study 35900835 — intervention group
Group type: EXPERIMENTAL
Intervention: Smiling Instead of Smoking app (version 2)
Number of subjects: 100
Study 35901014 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients aged 60 years or older
Number of subjects: 0
Study 35901014 — intervention group
Group type: COMPARATOR
Intervention: Patients aged 40-59 years
Number of subjects: 0
Study 35901014 — intervention group
Group type: COMPARATOR
Intervention: Patients aged 18-39 years
Number of subjects: 0
Study 35901272 — intervention group
Group type: EXPERIMENTAL
Intervention: Low- and no-calorie sweetened beverages (LNCSB)
Number of subjects: 416830
Study 35901272 — intervention group
Group type: EXPERIMENTAL
Intervention: Substitution of LNCSB for sugar-sweetened beverages (SSB)
Number of subjects: 416830
Study 35901272 — intervention group
Group type: EXPERIMENTAL
Intervention: Substitution of water for SSB
Number of subjects: 416830
Study 35901423 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 0
Study 35901693 — intervention group
Group type: EXPERIMENTAL
Intervention: LCTOPC1 (2 × 106, 1 × 107, or 2 × 107 cells) administered via intraparenchymal injection
Number of subjects: 25
Study 35901693 — intervention group
Group type: EXPERIMENTAL
Intervention: LCTOPC1
Number of subjects: 25
Study 35901717 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (60 cases: 21 microsurgery, 19 embolization, 20 hybrid surgery)
Number of subjects: 82
Study 35901717 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 82
Study 35901717 — intervention group
Group type: EXPERIMENTAL
Intervention: Microsurgery and hybrid surgery
Number of subjects: 82
Study 35901717 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid surgery
Number of subjects: 82
Study 35901717 — intervention group
Group type: COMPARATOR
Intervention: Conservative management (22 cases)
Number of subjects: 82
Study 35901755 — intervention group
Group type: EXPERIMENTAL
Intervention: Target Ultra and Nano coils
Number of subjects: 100
Study 35901765 — intervention group
Group type: EXPERIMENTAL
Intervention: Framingham Risk Score (FRS)
Number of subjects: 140
Study 35901765 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic Coronary Risk Evaluation-Older Persons (SCORE-OP)
Number of subjects: 140
Study 35901765 — intervention group
Group type: EXPERIMENTAL
Intervention: Kiefer's Comorbidity Index (KCI)
Number of subjects: 140
Study 35902154 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental hygienists
Number of subjects: 8902
Study 35902154 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentists
Number of subjects: 8902
Study 35902154 — intervention group
Group type: COMPARATOR
Intervention: Unvaccinated but planning on getting vaccinated
Number of subjects: 8902
Study 35902154 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccinated respondents
Number of subjects: 8902
Study 35902169 — intervention group
Group type: EXPERIMENTAL
Intervention: Watchman device implantation with PDL≤5 at 1 year
Number of subjects: 1054
Study 35902169 — intervention group
Group type: COMPARATOR
Intervention: Watchman device implantation without PDL≤5 at 1 year
Number of subjects: 1054